Asthma and COPD Flashcards
2 anticholinergics
ipratropium bromide
tiotropium bromide
5 corticosteroids
beclomethasone
budesonide
fluticasone
oral prednisone
IV methylprednisolone
4 beta agonists (-terol)
albuterol
levalbterol
salmeterol
formoterol
1 phosphodiesterase-5 inhibitors
roflumilast
2 Leukotriene receptor agonists
montelukast
zafirlukast
1 5-lipoxygenase inhibitor
zileuton
Anticholinergic MOA
block muscarinic receptors, reducing bronchoconstriction
Anticholinergic SE
dry mouth, cough, urinary retention
Corticosteroids MOA
anti-inflam; reduce airway inflam
Corticosteroids SE
oral thrush, hoarseness, cough, potential reduced bone density
Beta-2 agonists MOA (short and long acting)
Short: activate beta-2 receptors to relax bronchial smooth muscles
Long: same as short but with prolonged action
Beta-2 agonists SE
Tachycardia, palpitations, tremors, nervousness
Long acting are less frequent
Phosphodiesterase-5 Inhibitors MOA
reduces inflam by inhibiting phosphodiesterase-4 enzyme; reduces risk of exacerbations in severe COPD
Phosphodiesterase-5 Inhibitors SE
diarrhea, weight loss, nausea, headache, insomnia
leukotriene receptor agonists MOA
block leukotriene receptors (antagonists)